Honey Dressing - A Preventive Procedure for Post-Surgical Site Infection
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Signs of Wound Infection
研究概览
简要总结
The goal of this clinical trial is to compare the wound healing in the participants who underwent the clean surgical procedure, by applying honey dressing and common Iodine solution dressing, participants will have no other co-morbidities like Diabetes, Anemia, etc. which can make the results biased. The main questions it aims to answer are:
- Do the iodine solutions are enough to counter the infections caused by resistant strains of bacteria?
- What is the efficacy and efficiency of honey dressing in wound care?
Participants will be tasked to
- Ensure strict follow-up in the hospital dressing room
- Half of the participants will apply common iodine solution dressing and the other half will be applied honey dressing.
Researchers will compare Iodine dressing (Control group) with Honey dressing (Experimental group) to see if Honey dressing is better in the prevention of post-surgery wound infection and if it is cost-efficient and its efficacy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 12 Years 至 50 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with sterile/clean post-surgical wounds are admitted in general surgery, neurosurgery, orthopedic, and gynecology wards and require follow-up dressings.
排除标准
- •Patients with:
- •Local Infection in wound area.
- •Venous leg ulcers
- •Immunocompromised (Oncological patients)
- •Patient under negative pressure therapy
研究组 & 干预措施
Honey
Participants will get honey dressings in their follow-up visits to the dressing room.
干预措施: Honey Dressing (Biological)
Aseptic Iodine
Participants will get iodine solution dressings in their follow-up visits to the dressing room.
干预措施: Iodine Dressing (Drug)
结局指标
主要结局
Signs of Wound Infection
时间窗: 3rd day, 7th day, 15th day.
Presence of exudate, warmth, pus, erythema, dehiscence, contact bleeding, and any systemic sign like fever, rash, and myalgia.
次要结局
未报告次要终点
研究者
Syed Muhammad Ali Haider
House Officer Neurosurgery
HITEC-Institute of Medical Sciences